Login to Your Account

Uncertainties Remain

FDA Denial of Teva Petition Might Be Good News for Momenta

By Trista Morrison

Friday, May 14, 2010
The FDA denied Teva Pharmaceuticals Inc.'s latest attempt to block generic competition to Copaxone (glatiramer acetate) - but hurdles remain for generic Copaxone maker Momenta Pharmaceuticals Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription